Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Metabolism”

1,848 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,848 results

Not applicableStudy completedNCT03233178
What this trial is testing

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
LMC Diabetes & Endocrinology Ltd. 4,000
Not applicableWithdrawnNCT02863393
What this trial is testing

Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Taipei Medical University WanFang Hospital
Not applicableEnded earlyNCT01100749
What this trial is testing

Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada

Who this might be right for
Chronic Hepatitis C - Genotype 3
University Health Network, Toronto 25
Not applicableStudy completedNCT03836443
What this trial is testing

Postprandial Lipotoxicity and Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Assistance Publique - Hôpitaux de Paris 30
Not applicableUnknownNCT01898325
What this trial is testing

Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan

Who this might be right for
Fibrosis
Rambam Health Care Campus 40
Post-approval studies (Phase 4)Study completedNCT02019784
What this trial is testing

Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy

Who this might be right for
Liver CirrhosisHepatoencephalopathy, Early Fatal Progressive
King's College Hospital NHS Trust 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07173933
What this trial is testing

Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)

Who this might be right for
Wilson Disease
GeneCradle Inc 15
Not applicableStudy completedNCT05124847
What this trial is testing

TREating Pediatric Obesity

Who this might be right for
Infant ObesityHepatic SteatosisMetabolic Syndrome+2 more
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 30
Not applicableUnknownNCT02400099
What this trial is testing

Protein-rich Diet and NAFLD in Bariatric Surgery

Who this might be right for
ObesityNon-alcoholic Fatty Liver Disease
Catholic University of the Sacred Heart 60
Not applicableStudy completedNCT02163837
What this trial is testing

Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Centre Hospitalier Universitaire Saint Pierre 15
Not applicableStudy completedNCT06762509
What this trial is testing

The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease

Who this might be right for
Wilson Disease
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine 60
Not applicableStudy completedNCT02488993
What this trial is testing

Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)

Who this might be right for
Hepatic Encephalopathy
Norgine 389
Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Not applicableStudy completedNCT05572125
What this trial is testing

Iron Therapy in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic ProtoporphyriaIron-deficiency
Bispebjerg Hospital 10
Not applicableNot Yet RecruitingNCT07241832
What this trial is testing

Multifaceted Assessment of Patients With Wilson's Disease in a Low-Resource Setting in Upper Egypt: Service Integration, Psychosocial Burden, Dietary Practices, and the Geo-Spatial Disease Map

Who this might be right for
Wilson's Disease
Assiut University 66
Testing effectiveness (Phase 2)Looking for participantsNCT04501406
What this trial is testing

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis
University of Florida 166
Post-approval studies (Phase 4)Study completedNCT00998335
What this trial is testing

Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Florida 30
Large-scale testing (Phase 3)Looking for participantsNCT06910358
What this trial is testing

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
Disc Medicine, Inc 150
Not applicableStudy completedNCT00305591
What this trial is testing

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Who this might be right for
CirrhosisHepatic Encephalopathy
Imperial College London 50
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Load More Results